---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-25-000029"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:43:01.256201+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q2 revenue down 8% to $549M, but GAAP net income of $35.3M vs year-ago loss

## Summary
- Revenue $548.9M vs $596.5M YoY; GAAP gross margin improved to 38% from 35%.
- GAAP net income $35.3M ($1.43 diluted EPS) vs net loss of $(21.4M) ($(0.88) EPS) in Q2 2024.
- Adjusted diluted EPS $2.10 vs $1.56 YoY; Adjusted EBITDA $100.3M vs $91.3M.
- Fiscal 2025 guidance updated in the press release; specifics not provided in excerpt.

## SEC filing metadata
- accession: 0000883984-25-000029
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398425000029/0000883984-25-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398425000029/icui-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-25-000029
- JSON: https://secwatch.observer/filing/0000883984-25-000029.json
- Plain text: https://secwatch.observer/filing/0000883984-25-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.